Werewolf Therapeutics Inc

HOWLNASDAQ · USD
0.90USD-0.03 (-3.42%)
4510

Werewolf Therapeutics Inc (HOWL) Historical Volatility

HOWL 30-day historical volatility is 210%. This ranks in the 93th percentile of readings over the past year.

Read more

Tracking HOWL historical volatility helps you see how much Werewolf Therapeutics Inc's stock price has actually moved over past periods, giving you a baseline to judge whether current option premiums are fair, cheap, or expensive. While implied volatility tells you what the market expects, Werewolf Therapeutics Inc's HV tells you what really happened. Use our scanner to monitor HOWL 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.

Historical volatility is the annualized standard deviation of an underlying's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. The HOWL 30 day historical volatility is one of the most widely watched readings because it balances responsiveness with stability. Comparing Werewolf Therapeutics Inc's HV to its implied volatility reveals the volatility risk premium — when IV sits well above HV, option sellers tend to have an edge; when HV runs hot relative to IV, buyers may be underpaying for movement.

Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of relapsed or refractory advanced or metastatic solid tumors or lymphoma.

The company is also developing WTX-613, a conditionally activated interferon alpha INDUKINE molecule for the treatment of solid tumors and hematologic malignancies. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.

Sizing a long premium trade, modeling a covered call, or hunting volatility arbitrage all come back to one question: how much has the stock actually moved? Our scanner puts Werewolf Therapeutics Inc's historical volatility side-by-side with implied readings across every lookback window, so you can see exactly where HOWL HV is running hot, cold, or in line. Make the HOWL 30 day historical volatility — and every other window — work for your edge instead of against it.

IV vs HV
Implied Volatility (IV) vs Historical Volatility (HV) over the past month.

As of September 28, 2026

IV - HV Difference
Difference between IV and HV over time. Positive values indicate IV > HV.

As of September 28, 2026

See how volatility has moved over time

Track HOWL historical volatility, spot where IV and realized volatility diverge, and find options that are priced in your favor right now.

Start your 14-day free trial